| William Mccormick, DO | |
|
1951 Frontage Rd, Sierra Vista, AZ 85635-4606 | |
| (520) 458-0650 | |
| (520) 459-7030 |
| Full Name | William Mccormick |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 1951 Frontage Rd, Sierra Vista, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720008105 | NPI | - | NPPES |
| 213447 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 1463 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Mccormick, DO 302 El Camino Real, Ste 5, Sierra Vista, AZ 85635-2860 Ph: (520) 458-4335 | William Mccormick, DO 1951 Frontage Rd, Sierra Vista, AZ 85635-4606 Ph: (520) 458-0650 |
News Archive
South Carolina Attorney General Henry McMaster will discuss the review of state attorneys general into the constitutionality of the health care reform bill being considered by Congress, at a National Press Club Newsmaker press conference at 2:00 p.m. on Wednesday, January 13th, in the Zenger Room, 13th Floor, National Press Building, 529 14th Street, NW, Washington, DC.
Laboratory-based treatment reminders meant to improve physicians' prescribing habits for patients with chronic kidney disease (CKD) may not be effective, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
Immunotherapy, genomic profiling, and investigating game-changing drug therapies topped the list of most important cancer research and clinical developments at Dana-Farber Cancer Institute in 2014.
A technology that can enhance collecting of data from studying the compositions on a material surface has earned the Department of Energy's Oak Ridge National Laboratory the Excellence in Technology Transfer Project of the Year Award from the Southeast Region of the Federal Laboratory Consortium for Technology Transfer.
Baxter International Inc. and New York-Presbyterian Hospital/Weill Cornell Medical Center today announced results of an 18-month Phase II clinical study of GAMMAGARD LIQUID and GAMMAGARD S/D [Immune Globulin Intravenous (Human)] (marketed as KIOVIG outside of the U.S.) for mild-to-moderate Alzheimer's disease. This marked the first announcement of clinical trial results measuring function and cognition in patients who received uninterrupted GAMMAGARD for a period of 18 months.
› Verified 8 days ago
Laurence M Susini, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 155 Calle Portal, #100, Sierra Vista, AZ 85635 Phone: 520-458-6088 Fax: 520-458-3983 | |
Carol L Hulett, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1951 Frontage Rd, Sierra Vista, AZ 85635 Phone: 520-458-0650 Fax: 520-459-7030 |